Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Aliqopa
Pharma
Bayer, Novo separately opt to discontinue their Aliqopa, Levemir
While Bayer's Aliqopa couldn't prove its worth in a confirmatory trial, Novo's Levemir faced manufacturing issues and troubles with patient coverage.
Zoey Becker
Nov 9, 2023 9:10am
Bayer needs acquisition to meet oncology sales goal, exec says
Jun 12, 2023 2:19pm
FDA halts single-arm nods for PI3K blood cancer meds
Apr 20, 2022 9:57am
Bayer poaches GSK exec to lead oncology business
Feb 7, 2022 10:39am
Bayer's Aliqopa leaps ahead of Gilead's Zydelig in lymphoma
Apr 10, 2021 8:30am
Bayer gears up to take on Gilead with Aliqopa green light
Sep 15, 2017 4:35am
